Most studies that have addressed the association between the levels of inflammation and disease in patients with PD have defined inflammation using the plasma concentrations of C-reactive protein (CRP), interleukin-6 (IL-6) or tumor necrosis factor (TNF). This evidence concerns the gene IL6 and Parkinson disease.